This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tsubuku, S. Articles by Kimura, T. Search for Related Content PubMed PubMed Citation Articles by Tsubuku, S. Articles by Kimura, T. Social Bookmarking                         What's this?

Thirteen-Week Oral Toxicity Study of L-Arginine in Rats

¹ Health Services Development Department, Ajinomoto Co., Inc., Tokyo, Japan
² The Second Laboratory for Safety Evaluation, Gotemba Laboratory, Bozo Research Center Inc., Tokyo, Japan
³ Amino Acid Department, Ajinomoto Co., Inc., Tokyo, Japan
⁴ Quality Assurance and External Scientific Affairs Department, Ajinomoto Co., Inc., Tokyo, Japan

Correspondence: Address correspondence to Takeshi Kimura, Quality Assurance and External Scientific Affairs Department, Ajinomoto Co., Inc., 1-15-1 Chuo-ku, 104-8315 Tokyo, Japan. E-mail:takeshi_kimura{at}ajinomoto.com

The amino acid L-arginine (Arg) has been used extensively in dietary and pharmacological products. This study evaluated toxicological and behavioral effects of Arg produced by Ajinomoto Co. (Tokyo, Japan) during a dosing study with male and female Sprague-Dawley rats. The amino acid was incorporated into a standard diet at doses equal to 1.25%, 2.5%, and 5.0% (w/w). A control group of rats received only a standard diet. All diets were administered ad libitum for 13 continuous weeks. To examine recoverability of any potential effects, the administration period was followed by a 5-week-long recovery, during which only a standard diet was provided. In male and female rats in each concentration group, treatment-related changes were not observed for clinical signs, body weights, diet consumption, ophthalmology, gross pathology, organ weight, or histopathology. An elevated level of plasma glucose was detected in some male rats (5.0%, w/w) during the analysis conducted in the fifth week of administration; however, the degree of the change was within the physiological range, and no changes were observed at the end of the administration period. In the same group, an increase in hemoglobin, together with a tendency toward an increase in the red blood cell counts, was found, but the change was considered toxicologically insignificant. The no-observed-adverse-effect level (NOAEL) for Arg was estimated at 5.0% (w/w) for both genders (males, 3.3 ±0.1 g/kg/day; females, 3.9 ±0.2 g/kg/day).

Key Words: L-Arginine • NOAEL • Rat • Safety • Subchronic Toxicity

International Journal of Toxicology, Vol. 23, No. 2, 101-105 (2004)
DOI: 10.1080/10915810490435622


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?